Magazine date:
May 2021 
On 19 May 2021, the European Commission outlined its plan to lift intellectual property on Covid-19 vaccines. However, the positions of the member states on this issue remain different. As an example, Germany is opposed to this proposal.
In the United States, the American president declared on 5 May that he supports the temporary lifting of patents.
It is worth recalling that South Africa and India have long advocated for a large-scale lifting of intellectual property rights on vaccines.
Read also | Covid-19: debate on patent lift [4]